Skip to content

Study · Animal study (in vivo) · mouse · 2024

17 results

β-Nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice.

Gu Y, Gao L, He J, Luo M, Hu M, Lin Y, Li J, Hou T, Si J, Yu Y

Food & function18 Mar 2024Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study17

17 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In prematurely aged Zmpste24-deficient mice, NMN prolonged lifespan.

    In plain wordsIn mice with premature aging, NMN prolonged lifespan.

    Outcome
    IncreaseLifespan
    Study

    mousen: not reported in source

    Zmpste24-deficient prematurely aged mice
    Outcome group
    Mortality · Aging and longevity
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In our research, Zmpste24-/- mice proved that NMN prolonged their life span and delayed senescence.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In prematurely aged mice, NMN delayed senescence.

    In plain wordsIn mice with premature aging, NMN delayed senescence.

    Outcome
    DecreaseSenescence
    Study

    mousen: not reported in source

    Zmpste24-deficient prematurely aged mice
    Outcome group
    Aging markers · Aging and longevity
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In our research, Zmpste24-/- mice proved that NMN prolonged their life span and delayed senescence.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN improved intestinal epithelial pathology.

    In plain wordsIn mice, NMN improved damage in intestinal lining cells.

    Outcome
    DecreaseIntestinal epithelial pathology
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  4. 04AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN improved intestinal permeability.

    In plain wordsIn mice, NMN improved intestinal permeability.

    Outcome
    DecreaseIntestinal permeability
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  5. 05AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased intestinal tight junction protein expression.

    In plain wordsIn mice, NMN increased intestinal tight junction proteins.

    Outcome
    IncreaseTight junction proteins
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  6. 06AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased goblet cell numbers.

    In plain wordsIn mice, NMN increased intestinal goblet cell numbers.

    Outcome
    IncreaseGoblet cell number
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  7. 07AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased anti-inflammatory factor release.

    In plain wordsIn mice, NMN increased the release of anti-inflammatory factors.

    Outcome
    IncreaseAnti-inflammatory factor release
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Inflammation markers · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  8. 08AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased beneficial intestinal bacteria.

    In plain wordsIn mice, NMN increased beneficial intestinal bacteria.

    Outcome
    IncreaseBeneficial intestinal bacteria
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gut microbiota · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicated that NMN improved the pathology of intestinal epithelial cells and intestinal permeability by upregulating the expression of intestinal tight junction proteins and the number of goblet cells, increasing the release of anti-inflammatory factors, and increasing beneficial intestinal bacteria.
  9. 09AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased SIRT1 protein expression.

    In plain wordsIn mice, NMN increased SIRT1 protein levels.

    Outcome
    IncreaseSIRT1 expression
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN increased the expression of the proteins SIRT1, NMNAT2, and NMNAT3 and decreased the expression of the protein P53.
  10. 10AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased NMNAT2 protein expression.

    In plain wordsIn mice, NMN increased NMNAT2 protein levels.

    Outcome
    IncreaseNMNAT2 expression
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN increased the expression of the proteins SIRT1, NMNAT2, and NMNAT3 and decreased the expression of the protein P53.
  11. 11AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased NMNAT3 protein expression.

    In plain wordsIn mice, NMN increased NMNAT3 protein levels.

    Outcome
    IncreaseNMNAT3 expression
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN increased the expression of the proteins SIRT1, NMNAT2, and NMNAT3 and decreased the expression of the protein P53.
  12. 12AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN decreased P53 protein expression.

    In plain wordsIn mice, NMN reduced P53 protein levels.

    Outcome
    DecreaseP53 expression
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN increased the expression of the proteins SIRT1, NMNAT2, and NMNAT3 and decreased the expression of the protein P53.
  13. 13AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased Wnt/β-catenin signaling associated with intestinal stem cell regulation.

    In plain wordsIn mice, NMN increased Wnt/β-catenin signaling in intestinal stem cell regulation.

    Outcome
    IncreaseWnt/β-catenin
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It also regulated the activity of ISCs by increasing Wnt/β-catenin and Lgr5.
  14. 14AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased Lgr5.

    In plain wordsIn mice, NMN increased Lgr5.

    Outcome
    IncreaseLgr5
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It also regulated the activity of ISCs by increasing Wnt/β-catenin and Lgr5.
  15. 15AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased relative Akkermansia muciniphila abundance.

    In plain wordsIn mice, NMN increased the relative abundance of Akkermansia muciniphila.

    Outcome
    IncreaseAkkermansia muciniphila abundance
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gut microbiota · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our findings also revealed that NMN caused a significant increase in the relative abundance of Akkermansia muciniphila and Bifidobacterium pseudolongum and notable differences in metabolic pathways related to choline metabolism in cancer.
  16. 16AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN increased relative Bifidobacterium pseudolongum abundance.

    In plain wordsIn mice, NMN increased the relative abundance of Bifidobacterium pseudolongum.

    Outcome
    IncreaseBifidobacterium pseudolongum abundance
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Gut microbiota · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our findings also revealed that NMN caused a significant increase in the relative abundance of Akkermansia muciniphila and Bifidobacterium pseudolongum and notable differences in metabolic pathways related to choline metabolism in cancer.
  17. 17AnimalAnimal study (in vivo)Mechanism

    In aging mice, NMN altered pathways related to choline metabolism in cancer.

    In plain wordsIn mice, NMN altered pathways related to choline metabolism in cancer.

    Outcome
    Direction not reportedCholine metabolism pathways
    Study

    mousen: not reported in source

    aging mice
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our findings also revealed that NMN caused a significant increase in the relative abundance of Akkermansia muciniphila and Bifidobacterium pseudolongum and notable differences in metabolic pathways related to choline metabolism in cancer.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.